A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer
{{output}}
Background: Immune checkpoint inhibitors (ICI) have emerged as active therapies in the management of advanced RCC. While multiple studies have shown clinical activity of ICIs in clear cell histologies, the evidence to support the... ...
